SRS Capital Advisors Inc. Grows Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

SRS Capital Advisors Inc. grew its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 308.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 408 shares of the company’s stock after purchasing an additional 308 shares during the period. SRS Capital Advisors Inc.’s holdings in U.S. Physical Therapy were worth $38,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Envestnet Asset Management Inc. grew its holdings in shares of U.S. Physical Therapy by 53.2% during the 3rd quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company’s stock valued at $15,040,000 after purchasing an additional 56,957 shares during the last quarter. Bahl & Gaynor Inc. increased its holdings in shares of U.S. Physical Therapy by 95.5% in the fourth quarter. Bahl & Gaynor Inc. now owns 100,315 shares of the company’s stock worth $9,343,000 after buying an additional 49,013 shares during the period. Schroder Investment Management Group lifted its stake in shares of U.S. Physical Therapy by 12.1% in the 3rd quarter. Schroder Investment Management Group now owns 384,936 shares of the company’s stock valued at $35,310,000 after acquiring an additional 41,414 shares during the last quarter. Northern Trust Corp lifted its stake in shares of U.S. Physical Therapy by 9.5% in the 3rd quarter. Northern Trust Corp now owns 227,704 shares of the company’s stock valued at $20,887,000 after acquiring an additional 19,661 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in U.S. Physical Therapy by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock valued at $95,051,000 after acquiring an additional 17,156 shares during the period.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.26, for a total transaction of $260,650.00. Following the completion of the transaction, the director now owns 5,780 shares of the company’s stock, valued at $602,622.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Carey P. Hendrickson sold 1,800 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $107.28, for a total value of $193,104.00. Following the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of U.S. Physical Therapy stock in a transaction on Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the transaction, the director now owns 5,780 shares of the company’s stock, valued at approximately $602,622.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 10,829 shares of company stock valued at $1,141,535. Corporate insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Trading Up 1.5 %

NYSE USPH opened at $105.20 on Friday. The stock has a market cap of $1.59 billion, a P/E ratio of 77.93, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39. U.S. Physical Therapy, Inc. has a fifty-two week low of $78.08 and a fifty-two week high of $124.11. The stock has a 50 day simple moving average of $105.10 and a two-hundred day simple moving average of $96.01. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.28 and a current ratio of 2.28.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The company had revenue of $154.80 million during the quarter, compared to analyst estimates of $150.24 million. During the same quarter last year, the firm posted $0.58 earnings per share. The firm’s revenue was up 9.6% on a year-over-year basis. On average, analysts forecast that U.S. Physical Therapy, Inc. will post 2.77 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were issued a dividend of $0.44 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date was Monday, March 11th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.67%. U.S. Physical Therapy’s dividend payout ratio is 130.37%.

Analyst Upgrades and Downgrades

USPH has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 13th. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Finally, Barrington Research increased their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.